House Bill 572 authorizes the North Carolina Department of Military and Veterans Affairs to select a provider to establish a statewide pilot program offering electroencephalogram combined transcranial magnetic stimulation treatment, or eTMS, to veterans, first responders, and their immediate family members. The program is intended to address a broad set of behavioral health and neurological conditions, including substance use disorders, mental illness, sleep disorders, traumatic brain injuries, sexual trauma, posttraumatic stress disorder, concussions, other brain trauma, and cognitive or attention-related quality-of-life issues.
The bill sets out detailed requirements for the pilot. The selected provider must have statewide experience serving veterans and first responders, create both in-person and off-site care networks, and evaluate clinical outcomes. The program must also include peer-to-peer support, counseling and wellness programming, neurophysiological monitoring, and treatment protocols based on EEGs, motor threshold testing, symptoms, and biometrics. The provider must report treatment protocols, outcomes, and expenditures using state funds to legislative and fiscal oversight entities by September 15, 2026, and the department may adopt rules to implement the act.
HB572 would create a new state-run pilot program within the Department of Military and Veterans Affairs and authorize the department to contract with a provider to deliver eTMS services statewide. It does not amend existing benefit programs directly, but it would establish a new statutory framework for treatment access, reporting, and oversight for veterans, first responders, and their immediate family members. The bill also gives the department rulemaking authority and requires reporting to legislative oversight and fiscal staff, which would affect how the program is administered and evaluated.
The bill appears generally supportive and service-oriented, with its focus on expanding treatment options for veterans and first responders who may be dealing with PTSD, brain injuries, substance use, and related conditions. The absence of recorded votes or committee transcripts limits insight into formal debate, but the bill’s structure suggests an emphasis on innovation, access, and accountability rather than controversy. Its referral history indicates it moved through the House and was sent to the Senate Rules committee, but no recorded opposition or amendment activity is available in the provided materials.
The main potential points of contention are likely to be the use of state funds for a relatively specialized treatment pilot, the evidence base and effectiveness of eTMS, and the selection of a provider with statewide reach. The bill’s inclusion of nonmedical portable magnetic stimulation devices and its broad treatment categories could also raise questions about clinical standards, oversight, and whether the program is sufficiently targeted. Another possible issue is the requirement that participants engage in peer-to-peer support and monitoring, which may be viewed as beneficial by supporters but potentially burdensome by critics.